Session Information
Session Type: Abstract Submissions (ACR)
Background/Purpose
Hypoxia exists in many diseased tissues including arthritic joints, atherosclerotic plaques and malignant tumours. Macrophages accumulate in these hypoxic sites where they possess broad pro-inflammatory, destructive and remodelling potential leading to inflammation and joint destruction. Macrophages respond to hypoxia by up regulating the hypoxia inducible transcription factors– HIF-1 and -2, which leads to the up-regulation of genes involved in proliferation, angiogenesis, and glucose metabolism.
The purpose of our study was to characterise the HIF-2 expressing macrophage populations in response to joint hypoxia, and in particular to dissect out the effects of HIF-2 in a murine model of arthritis.
Methods
Arthroscopy sections from RA patients with mild (~40mmHg) or severe (~3mmHg) joint hypoxia were immunostained with anti-HIF 2 and co-localised with the pan-macrophage marker CD68 as well as other M1 and M2 macrophage markers. Cell-specific RNA was purified from CD68+ve macrophages in RA tissue by laser capture microdissection (LCM) and differential gene expression was determined using the RT2 Profiler PCR inflammatory arrays. The significance of HIF-2 was also evaluated in the K/BxN serum transfer model in mice bearing a targeted deletion of HIF-2 in myeloid cells including macrophages (HIF2fl/fl; LysM-Cre+’ mice). Arthritis was assessed clinically and histologically.
Results
In patients with severely hypoxic joints macrophages predominately expressed HIF-2 as well receptors for VEGF (Flt1), angiopoietin ‘Tie2’ and mannose ‘CD206’ markers associated with M2-skewed macrophages. However, expression of CXCL-2, -4, -5, IL-1a, IL-6 IL-8 & TNFa were also all up regulated compared to macrophages from mildly hypoxic joints. In vivo, macrophages lacking HIF2 significantly suppressed disease development indicating an indispensable role for HIF2 in supporting macrophages in K/BxN serum-transfer arthritis.
Conclusion
HIF-2 expressing macrophages have an M1 & M2-like phenotype in patients with severely hypoxic joints and loss of HIF-2 in macrophages suppressed arthritis in mice. Collectively, our data identify HIF-2 as an important regulator of macrophage function, suggesting it may be a useful therapeutic target for treating RA.
Disclosure:
M. Muthana,
None;
W. J. Hardy,
None;
S. Hawtree,
None;
F. Wright,
None;
U. Fearon,
None;
D. Veale,
None;
M. Perretti,
None;
A. G. Wilson,
None.
« Back to 2014 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/macrophage-expression-of-hypoxia-inducible-factor-2-alpha-promotes-rheumatoid-arthritis-progression/